FDA Proposes Changes to Biologics Regulations to Simplify Licensing Process

Summary

The FDA is proposing to eliminate the need for establishment licenses and product licenses for biological products regulated under the Public Health Service Act, instead requiring a single biologics license application for marketing in interstate commerce.